Rare Copy Number Variations in Adults with Tetralogy of Fallot Implicate Novel Risk Gene Pathways
Structural genetic changes, especially copy number variants (CNVs), represent a major source of genetic variation contributing to human disease. Tetralogy of Fallot (TOF) is the most common form of cyanotic congenital heart disease, but to date little is known about the role of CNVs in the etiology of TOF. Using high-resolution genome-wide microarrays and stringent calling methods, we investigated rare CNVs in a prospectively recruited cohort of 433 unrelated adults with TOF and/or pulmonary atresia at a single centre. We excluded those with recognized syndromes, including 22q11.2 deletion syndrome. We identified candidate genes for TOF based on converging evidence between rare CNVs that overlapped the same gene in unrelated individuals and from pathway analyses comparing rare CNVs in TOF cases to those in epidemiologic controls. Even after excluding the 53 (10.7%) subjects with 22q11.2 deletions, we found that adults with TOF had a greater burden of large rare genic CNVs compared to controls (8.82% vs. 4.33%, p = 0.0117). Six loci showed evidence for recurrence in TOF or related congenital heart disease, including typical 1q21.1 duplications in four (1.18%) of 340 Caucasian probands. The rare CNVs implicated novel candidate genes of interest for TOF, including PLXNA2, a gene involved in semaphorin signaling. Independent pathway analyses highlighted developmental processes as potential contributors to the pathogenesis of TOF. These results indicate that individually rare CNVs are collectively significant contributors to the genetic burden of TOF. Further, the data provide new evidence for dosage sensitive genes in PLXNA2-semaphorin signaling and related developmental processes in human cardiovascular development, consistent with previous animal models.
Vyšlo v časopise:
Rare Copy Number Variations in Adults with Tetralogy of Fallot Implicate Novel Risk Gene Pathways. PLoS Genet 8(8): e32767. doi:10.1371/journal.pgen.1002843
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pgen.1002843
Souhrn
Structural genetic changes, especially copy number variants (CNVs), represent a major source of genetic variation contributing to human disease. Tetralogy of Fallot (TOF) is the most common form of cyanotic congenital heart disease, but to date little is known about the role of CNVs in the etiology of TOF. Using high-resolution genome-wide microarrays and stringent calling methods, we investigated rare CNVs in a prospectively recruited cohort of 433 unrelated adults with TOF and/or pulmonary atresia at a single centre. We excluded those with recognized syndromes, including 22q11.2 deletion syndrome. We identified candidate genes for TOF based on converging evidence between rare CNVs that overlapped the same gene in unrelated individuals and from pathway analyses comparing rare CNVs in TOF cases to those in epidemiologic controls. Even after excluding the 53 (10.7%) subjects with 22q11.2 deletions, we found that adults with TOF had a greater burden of large rare genic CNVs compared to controls (8.82% vs. 4.33%, p = 0.0117). Six loci showed evidence for recurrence in TOF or related congenital heart disease, including typical 1q21.1 duplications in four (1.18%) of 340 Caucasian probands. The rare CNVs implicated novel candidate genes of interest for TOF, including PLXNA2, a gene involved in semaphorin signaling. Independent pathway analyses highlighted developmental processes as potential contributors to the pathogenesis of TOF. These results indicate that individually rare CNVs are collectively significant contributors to the genetic burden of TOF. Further, the data provide new evidence for dosage sensitive genes in PLXNA2-semaphorin signaling and related developmental processes in human cardiovascular development, consistent with previous animal models.
Zdroje
1. LeeC, SchererSW (2010) The clinical context of copy number variation in the human genome. Expert Rev Mol Med 12: e8.
2. BassettAS, SchererSW, BrzustowiczLM (2010) Copy number variations in schizophrenia: critical review and new perspectives on concepts of genetics and disease. Am J Psychiatry 167: 899–914.
3. LupskiJR (2007) Genomic rearrangements and sporadic disease. Nat Genet 39: S43–47.
4. StankiewiczP, LupskiJR (2002) Genome architecture, rearrangements and genomic disorders. Trends Genet 18: 74–82.
5. PintoD, PagnamentaAT, KleiL, AnneyR, MericoD, et al. (2010) Functional impact of global rare copy number variation in autism spectrum disorders. Nature 466: 368–372.
6. MarshallCR, NoorA, VincentJB, LionelAC, FeukL, et al. (2008) Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 82: 477–488.
7. ThienpontB, BreckpotJ, HolvoetM, VermeeschJR, DevriendtK (2007) A microduplication of CBP in a patient with mental retardation and a congenital heart defect. Am J Med Genet A 143A: 2160–2164.
8. ErdoganF, BellosoJM, GabauE, AjbroKD, GuitartM, et al. (2008) Fine mapping of a de novo interstitial 10q22-q23 duplication in a patient with congenital heart disease and microcephaly. Eur J Med Genet 51: 81–86.
9. RichardsAA, SantosLJ, NicholsHA, CriderBP, ElderFF, et al. (2008) Cryptic chromosomal abnormalities identified in children with congenital heart disease. Pediatr Res 64: 358–363.
10. Krepischi-SantosAC, Vianna-MorganteAM, JeheeFS, Passos-BuenoMR, KnijnenburgJ, et al. (2006) Whole-genome array-CGH screening in undiagnosed syndromic patients: old syndromes revisited and new alterations. Cytogenet Genome Res 115: 254–261.
11. PrescottK, IvinsS, HubankM, LindsayE, BaldiniA, et al. (2005) Microarray analysis of the Df1 mouse model of the 22q11 deletion syndrome. Hum Genet 116: 486–496.
12. GreenwaySC, PereiraAC, LinJC, DePalmaSR, IsraelSJ, et al. (2009) De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot. Nat Genet 41: 931–935.
13. LionelAC, CrosbieJ, BarbosaN, GoodaleT, ThiruvahindrapuramB, et al. (2011) Rare copy number variation discovery and cross-disorder comparisons identify risk genes for ADHD. Sci Transl Med 3: 95ra75.
14. EnsenauerRE, AdeyinkaA, FlynnHC, MichelsVV, LindorNM, et al. (2003) Microduplication 22q11.2, an emerging syndrome: clinical, cytogenetic, and molecular analysis of thirteen patients. Am J Hum Genet 73: 1027–1040.
15. HernandoC, PlajaA, RigolaM, PerezM, VendrellT, et al. (2002) Comparative genomic hybridisation shows a partial de novo deletion 16p11.2 in a neonate with multiple congenital malformations. J Med Genet 39: e24.
16. KohlhaseJ, WischermannA, ReichenbachH, FrosterU, EngelW (1998) Mutations in the SALL1 putative transcription factor gene cause Townes-Brocks syndrome. Nat Genet 18: 81–83.
17. ServilleF, LacombeD, SauraR, BilleaudC, SergentMP (1993) Townes-Brocks syndrome in an infant with translocation t (5;16). Genet Couns 4: 109–112.
18. DeimlingSJ, DrysdaleTA (2011) Fgf is required to regulate anterior-posterior patterning in the Xenopus lateral plate mesoderm. Mech Dev 128: 327–341.
19. SmithSA, MartinKE, DoddKL, YoungID (1994) Severe microphthalmia, diaphragmatic hernia and Fallot's tetralogy associated with a chromosome 1;15 translocation. Clin Dysmorphol 3: 287–291.
20. SoemediR, TopfA, WilsonIJ, DarlayR, RahmanT, et al. (2012) Phenotype-specific effect of chromosome 1q21.1 rearrangements and GJA5 duplications in 2436 congenital heart disease patients and 6760 controls. Hum Mol Genet 21: 1513–1520.
21. CostainG, SilversidesCK, MarshallCR, ShagoM, CostainN, et al. (2011) 13q13.1-q13.2 deletion in tetralogy of Fallot: clinical report and a literature review. Int J Cardiol 146: 134–139.
22. LamontRE, VuW, CarterAD, SerlucaFC, MacRaeCA, et al. (2010) Hedgehog signaling via angiopoietin1 is required for developmental vascular stability. Mech Dev 127: 159–168.
23. McDermidHE, MorrowBE (2002) Genomic disorders on 22q11. Am J Hum Genet 70: 1077–1088.
24. PeralaN (2012) More than nervous: The emerging roles of plexins. Differentiation 83: 77–91.
25. LalaniSR, SafiullahAM, MolinariLM, FernbachSD, MartinDM, et al. (2004) SEMA3E mutation in a patient with CHARGE syndrome. J Med Genet 41: e94.
26. NishimuraDY, SwiderskiRE, SearbyCC, BergEM, FergusonAL, et al. (2005) Comparative genomics and gene expression analysis identifies BBS9, a new Bardet-Biedl syndrome gene. Am J Hum Genet 77: 1021–1033.
27. NonakaS, TanakaY, OkadaY, TakedaS, HaradaA, et al. (1998) Randomization of left-right asymmetry due to loss of nodal cilia generating leftward flow of extraembryonic fluid in mice lacking KIF3B motor protein. Cell 95: 829–837.
28. UrnessLD, BleylSB, WrightTJ, MoonAM, MansourSL (2011) Redundant and dosage sensitive requirements for Fgf3 and Fgf10 in cardiovascular development. Dev Biol 356: 383–397.
29. KellyRG, BrownNA, BuckinghamME (2001) The arterial pole of the mouse heart forms from Fgf10-expressing cells in pharyngeal mesoderm. Dev Cell 1: 435–440.
30. GolzioC, HavisE, DaubasP, NuelG, BabaritC, et al. (2012) ISL1 directly regulates FGF10 transcription during human cardiac outflow formation. PLoS One 7: e30677.
31. LarriveeB, FreitasC, SuchtingS, BrunetI, EichmannA (2009) Guidance of vascular development: lessons from the nervous system. Circ Res 104: 428–441.
32. MillerDT, AdamMP, AradhyaS, BieseckerLG, BrothmanAR, et al. (2010) Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 86: 749–764.
33. PiranS, BassettAS, GrewalJ, SwabyJ-A, OeschlinE, et al. (2011) Patterns of cardiac and extra-cardiac anomalies in adults with tetralogy of Fallot. Am Heart J 161: 131–137.
34. RedonR, IshikawaS, FitchKR, FeukL, PerryGH, et al. (2006) Global variation in copy number in the human genome. Nature 444: 444–454.
35. MeffordHC, SharpAJ, BakerC, ItsaraA, JiangZ, et al. (2008) Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. N Engl J Med 359: 1685–1699.
36. Brunetti-PierriN, BergJS, ScagliaF, BelmontJ, BacinoCA, et al. (2008) Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities. Nat Genet 40: 1466–1471.
37. GuH, SmithFC, TaffetSM, DelmarM (2003) High incidence of cardiac malformations in connexin40-deficient mice. Circ Res 93: 201–206.
38. GollobMH, JonesDL, KrahnAD, DanisL, GongXQ, et al. (2006) Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation. N Engl J Med 354: 2677–2688.
39. GroenewegenWA, FirouziM, BezzinaCR, VliexS, van LangenIM, et al. (2003) A cardiac sodium channel mutation cosegregates with a rare connexin40 genotype in familial atrial standstill. Circ Res 92: 14–22.
40. RaperJA (2000) Semaphorins and their receptors in vertebrates and invertebrates. Curr Opin Neurobiol 10: 88–94.
41. TamagnoneL, ArtigianiS, ChenH, HeZ, MingGI, et al. (1999) Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell 99: 71–80.
42. FeinerL, WebberAL, BrownCB, LuMM, JiaL, et al. (2001) Targeted disruption of semaphorin 3C leads to persistent truncus arteriosus and aortic arch interruption. Development 128: 3061–3070.
43. BrownCB, FeinerL, LuMM, LiJ, MaX, et al. (2001) PlexinA2 and semaphorin signaling during cardiac neural crest development. Development 128: 3071–3080.
44. ToyofukuT, YoshidaJ, SugimotoT, YamamotoM, MakinoN, et al. (2008) Repulsive and attractive semaphorins cooperate to direct the navigation of cardiac neural crest cells. Dev Biol 321: 251–262.
45. LeporeJJ, MerickoPA, ChengL, LuMM, MorriseyEE, et al. (2006) GATA-6 regulates semaphorin 3C and is required in cardiac neural crest for cardiovascular morphogenesis. J Clin Invest 116: 929–939.
46. KodoK, NishizawaT, FurutaniM, AraiS, YamamuraE, et al. (2009) GATA6 mutations cause human cardiac outflow tract defects by disrupting semaphorin-plexin signaling. Proc Natl Acad Sci U S A 106: 13933–13938.
47. Theveniau-RuissyM, DadonneauM, MesbahK, GhezO, MatteiMG, et al. (2008) The del22q11.2 candidate gene Tbx1 controls regional outflow tract identify and coronary artery patterning. Circ Res 103: 142–148.
48. JinZ, ChauMD, BaoZZ (2006) Sema3D, Sema3F, and Sema5A are expressed in overlapping and distinct patterns in chick embryonic heart. Dev Dyn 235: 163–169.
49. KimJ, OhW-J, GaianoN, YoshidaY, GuC (2011) Semaphorin 3E–Plexin-D1 signaling regulates VEGF function in developmental angiogenesis via a feedback mechanism. Genes Dev 25: 1399–1411.
50. LalaniSR, SafiullahAM, FernbachSD, HarutyunyanKG, ThallerC, et al. (2006) Spectrum of CHD7 mutations in 110 individuals with CHARGE syndrome and genotype-phenotype correlation. Am J Hum Genet 78: 303–314.
51. KodoK, YamagishiH (2011) A decade of advances in the molecular embryology and genetics underlying congenital heart defects. Circ J 75: 2296–2304.
52. ChangS, McKinseyTA, ZhangCL, RichardsonJA, HillJA, et al. (2004) Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development. Mol Cell Biol 24: 8467–8476.
53. KaramboulasC, SwedaniA, WardC, Al-MadhounAS, WiltonS, et al. (2006) HDAC activity regulates entry of mesoderm cells into the cardiac muscle lineage. J Cell Sci 119: 4305–4314.
54. HaberlandM, ArnoldMA, McAnallyJ, PhanD, KimY, et al. (2007) Regulation of HDAC9 gene expression by MEF2 establishes a negative-feedback loop in the transcriptional circuitry of muscle differentiation. Mol Cell Biol 27: 518–525.
55. PomerleauD, GilbertG, ThibertD (1972) Kartagener's syndrome associated with tetralogy of Fallot. Union Med Can 101: 79–84.
56. KennedyMP, OmranH, LeighMW, DellS, MorganL, et al. (2007) Congenital heart disease and other heterotaxic defects in a large cohort of patients with primary ciliary dyskinesia. Circulation 115: 2814–2821.
57. IcardoJM, Sanchez de VegaMJ (1991) Spectrum of heart malformations in mice with situs solitus, situs inversus, and associated visceral heterotaxy. Circulation 84: 2547–2558.
58. DeveaultC, BillingsleyG, DuncanJL, BinJ, ThealR, et al. (2011) BBS genotype-phenotype assessment of a multiethnic patient cohort calls for a revision of the disease definition. Hum Mutat 32: 610–619.
59. RichardsEG, ZaveriHP, WolfVL, KangSH, ScottDA (2011) Delineation of a less than 200 kb minimal deleted region for cardiac malformations on chromosome 7p22. Am J Med Genet A 155A: 1729–1734.
60. ChenY, LiuYJ, PeiYF, YangTL, DengFY, et al. (2011) Copy number variations at the Prader-Willi syndrome region on chromosome 15 and associations with obesity in Whites. Obesity (Silver Spring) 19: 1229–1234.
61. BassettAS, MarshallCR, LionelAC, ChowEW, SchererSW (2008) Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome. Hum Mol Genet 17: 4045–4053.
62. BassettAS, ChowEW, HustedJ, HodgkinsonKA, OechslinE, et al. (2009) Premature death in adults with 22q11.2 deletion syndrome. J Med Genet 46: 324–330.
63. FungWL, ChowEW, WebbGD, GatzoulisMA, BassettAS (2008) Extracardiac features predicting 22q11.2 deletion syndrome in adult congenital heart disease. Int J Cardiol 131: 51–58.
64. SchererSW, LeeC, BirneyE, AltshulerDM, EichlerEE, et al. (2007) Challenges and standards in integrating surveys of structural variation. Nat Genet 39: S7–15.
65. PritchardJK (2001) Are rare variants responsible for susceptibility to complex diseases? Am J Hum Genet 69: 124–137.
66. KornJM, KuruvillaFG, McCarrollSA, WysokerA, NemeshJ, et al. (2008) Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs. Nat Genet 40: 1253–1260.
67. PintoD, DarvishiK, ShiX, RajanD, RiglerD, et al. (2011) Comprehensive assessment of array-based platforms and calling algorithms for detection of copy number variants. Nat Biotechno 29: 512–520.
68. KumarP, HenikoffS, NgPC (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4: 1073–1081.
69. AdzhubeiIA, SchmidtS, PeshkinL, RamenskyVE, GerasimovaA, et al. (2010) A method and server for predicting damaging missense mutations. Nat Methods 7: 248–249.
70. BansalV, LibigerO, TorkamaniA, SchorkNJ (2010) Statistical analysis strategies for association studies involving rare variants. Nat Rev Genet 11: 773–785.
71. MericoD, IsserlinR, StuekerO, EmiliA, BaderGD (2010) Enrichment map: A network-based method for gene-set enrichment visualization and interpretation. PLoS One 5: e13984.
Štítky
Genetika Reprodukčná medicínaČlánok vyšiel v časopise
PLOS Genetics
2012 Číslo 8
- Je „freeze-all“ pro všechny? Odborníci na fertilitu diskutovali na virtuálním summitu
- Gynekologové a odborníci na reprodukční medicínu se sejdou na prvním virtuálním summitu
Najčítanejšie v tomto čísle
- Dissecting the Gene Network of Dietary Restriction to Identify Evolutionarily Conserved Pathways and New Functional Genes
- It's All in the Timing: Too Much E2F Is a Bad Thing
- The PARN Deadenylase Targets a Discrete Set of mRNAs for Decay and Regulates Cell Motility in Mouse Myoblasts
- Novel Loci for Metabolic Networks and Multi-Tissue Expression Studies Reveal Genes for Atherosclerosis